Managed Access Programs for ABL001, Asciminib

NCT04360005 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Chronic Myeloid Leukemia in Chronic Phase

Interventions

DRUG: Asciminib

Sponsor

Novartis Pharmaceuticals